CYP3A5 and neuropathy: Consistently, antifungal drugs, such as itraconazole and voriconazole, inhibit the action of CYP3A5; consequently, coadministration of vincristine and these drugs decreases vincristine metabolism, leading to enhanced neuropathy side effects.